DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



CT Homepage

Siemens Healthineers installs first two SOMATOM go.Up CT platforms in the U.S. Situated at CDI outpatient imaging facilities in Missouri

Neusoft's NueViz Prime 128-slice CT scores FDA clearance High-speed system may improve imaging in trauma, pediatrics and cardiac cases

Researchers develop CT system for imaging extremely small objects Generates high-resolution 3-D images

Global PET/CT scanner market projected to reach $2.1 billion by 2023 Growth spurred in part by increased Medicare coverage

New AI software detects brain hemorrhages on CT scans Serves as a second opinion for radiologists

What do patients want most when it comes to imaging exams? New research attempts to answer one of health care's vital questions

New European project aims to protect patients and clinicians from low-dose radiation exposure Its recommendations may impact regulations

CT lung cancer screening combined with smoking cessation is worth expense $14,000 saved per quality-adjusted life-years gained: study

Bracco Imaging acquires SurgVision Enables development of a real-time fluorescence image-guided surgery platform

Study places CT among 10 most over-utilized medical exams... twice Ultrasound also makes the list

RYM1-labeled Tc-99m imaging
of carotid aneurysm on left

Courtesy of
Yale Cardiovascular Research Center

Yale researchers develop SPECT/CT tracer to risk-stratify patients with abdominal aortic aneurysm

by Lauren Dubinsky , Senior Reporter
As Sir William Osler put it, “There is no disease more conductive to clinical humility than aneurysm of the aorta.”

To date, there's no effective treatment for abdominal aortic aneurysm, but researchers at Yale University have developed a new imaging tracer that has the potential to risk-stratify patients with AAA.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory

“Rupture is the main complication of abdominal aortic aneurysms and it can be fatal. Larger aneurysms are at higher risk for rupture and usually undergo surgical or endovascular repair,” Dr. Mehran M. Sadeghi of the Yale Cardiovascular Research Center, told HCB News.

Smaller aneurysms are managed by monitoring their growth, but many of them that don’t meet criteria for repair do rupture, which can be fatal. The new tracer can be used with SPECT imaging to help monitor matrix metalloproteinase (MMP) activation, which is a process that underlies aneurysm rupture.

To form the basis of the new tracer, the Yale research team created a water-soluble MMP inhibitor. The RYM1-labeled Tc-99m tracer was then compared with another MMP tracer in mouse models of aneurysm.

These studies reveal that the tracer is capable of imaging vessel wall biology with high sensitivity and specificity. Aortic tracer uptake in vivo is associated with vessel wall inflammation.

The team concluded that SPECT/CT imaging with the RYM1-labeled Tc-99m tracer is a promising tool for stratifying risk and could provide new ways to manage AAA.

“If validated in humans, this technique would help identify patients with small aneurysms that are at high risk for rupture, to refer them for aneurysm repair,” said Sadeghi. “In addition, some patients with large aneurysms may not be at high risk for rupture.”

He added that the same approach could be applied to patients with large abdominal aortic aneurysms who are at high risk for surgery, in order to gauge their risk of rupture and potentially avoid unnecessary surgery.

Since the preclinical studied yielded promising results, Sadeghi and his team now have an Investigational New Drug Application underway to use RYM1-labeled Tc-99m in early-stage human studies.

CT Homepage


Don Bogutski

Yale develops a SPECT/CT tracer to risk stratify aortic aneurysm

August 05, 2017 04:26

I find it strange that a story about a new radio pharmaceutical which can stratify (quantify), the potential risk from an abdominal aortic aneurysm would be illustrated by an image of a carotid aneurysm. Why not show an example of the image applied to the problem which the drug purports to diagnose? There is a significant difference between the consequences of a problem found in a carotid artery from one found in an abdominal artery.

Log inor Register

to rate and post a comment

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2017, Inc.